methylphenidate has been researched along with Blood Pressure, High in 25 studies
Methylphenidate: A central nervous system stimulant used most commonly in the treatment of ATTENTION DEFICIT DISORDER in children and for NARCOLEPSY. Its mechanisms appear to be similar to those of DEXTROAMPHETAMINE. The d-isomer of this drug is referred to as DEXMETHYLPHENIDATE HYDROCHLORIDE.
methylphenidate : A racemate comprising equimolar amounts of the two threo isomers of methyl phenyl(piperidin-2-yl)acetate. A central stimulant and indirect-acting sympathomimetic, is used (generally as the hydrochloride salt) in the treatment of hyperactivity disorders in children and for the treatment of narcolepsy.
methyl phenyl(piperidin-2-yl)acetate : A amino acid ester that is methyl phenylacetate in which one of the hydrogens alpha to the carbonyl group is replaced by a piperidin-2-yl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Methylphenidate did not increase 24-h heart rates, whereas omega-3 fatty acid supplementation significantly decreased elevated heart rates and increased HRV in adolescents with IST." | 1.56 | Diagnosis and management of an inappropriate sinus tachycardia in adolescence based upon a Holter ECG: A retrospective analysis of 479 patients. ( Baumann, C; Buchhorn, R; Gündogdu, S; Rakowski, U; Willaschek, C, 2020) |
| "OROS-methylphenidate was reported as the most helpful methylphenidate class formulation, with 74% reporting it at least somewhat helpful." | 1.39 | Caregiver survey of pharmacotherapy to treat attention deficit/hyperactivity disorder in individuals with Williams syndrome. ( Andridge, RR; Coury, DL; Foster, JE; Martens, MA; McClure, KE; Seyfer, DL, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 13 (52.00) | 18.7374 |
| 1990's | 1 (4.00) | 18.2507 |
| 2000's | 4 (16.00) | 29.6817 |
| 2010's | 5 (20.00) | 24.3611 |
| 2020's | 2 (8.00) | 2.80 |
| Authors | Studies |
|---|---|
| Buchhorn, R | 1 |
| Baumann, C | 1 |
| Gündogdu, S | 1 |
| Rakowski, U | 1 |
| Willaschek, C | 1 |
| Cortese, S | 1 |
| Espadas, M | 1 |
| Insa, I | 1 |
| Chamorro, M | 1 |
| Alda-Diez, JA | 1 |
| Dela Peña, I | 1 |
| Kim, BN | 1 |
| Han, DH | 1 |
| Kim, Y | 1 |
| Cheong, JH | 1 |
| Martens, MA | 1 |
| Seyfer, DL | 1 |
| Andridge, RR | 1 |
| Foster, JE | 1 |
| McClure, KE | 1 |
| Coury, DL | 1 |
| Fernández-Fernández, MA | 1 |
| Rufo-Campos, M | 1 |
| Mateos-Checa, R | 1 |
| Muñoz-Cabello, B | 1 |
| Madruga-Garrido, M | 1 |
| Blanco-Martínez, B | 1 |
| Mick, E | 1 |
| McGough, JJ | 1 |
| Middleton, FA | 1 |
| Neale, B | 1 |
| Faraone, SV | 1 |
| Klein-Schwartz, W | 1 |
| McGrath, J | 1 |
| Oster, MI | 1 |
| HEYDECKE, KH | 2 |
| CHRISTE, R | 2 |
| ACHOR, RW | 1 |
| BERGE, KG | 1 |
| SCHLEGEL, G | 1 |
| DAY, MD | 1 |
| RAND, MJ | 1 |
| RIU, J | 1 |
| Wilens, TE | 1 |
| Hammerness, PG | 1 |
| Biederman, J | 1 |
| Kwon, A | 1 |
| Spencer, TJ | 1 |
| Clark, S | 1 |
| Scott, M | 1 |
| Podolski, A | 1 |
| Ditterline, JW | 1 |
| Morris, MC | 1 |
| Moore, H | 1 |
| van den Bergh, FS | 1 |
| Bloemarts, E | 1 |
| Chan, JS | 1 |
| Groenink, L | 1 |
| Olivier, B | 1 |
| Oosting, RS | 1 |
| Deshmankar, BS | 1 |
| Lewis, JA | 1 |
| Blackman, JA | 1 |
| Samson-Fang, L | 1 |
| Gutgesell, H | 1 |
| Kudrin, AN | 1 |
| Davydova, ON | 1 |
| Krendal', FP | 1 |
| Brown, RT | 1 |
| Sexson, SB | 1 |
| Brichard, G | 1 |
| Guilleminault, C | 1 |
| Carskadon, M | 1 |
| Dement, WC | 1 |
| Fischer, KC | 1 |
| Wilson, WP | 1 |
| Meyer, JS | 1 |
| Eadie, GA | 1 |
| Ericsson, AD | 1 |
| Hoobler, SW | 1 |
| MacMahon, HR | 1 |
3 reviews available for methylphenidate and Blood Pressure, High
| Article | Year |
|---|---|
Pharmacologic Treatment of Attention Deficit-Hyperactivity Disorder.
Topics: Adolescent; Adult; Amphetamines; Atomoxetine Hydrochloride; Attention Deficit Disorder with Hyperact | 2020 |
[Side effects of methylphenidate in children and the young].
Topics: Adolescent; Anorexia; Attention Deficit Disorder with Hyperactivity; Bone Diseases, Developmental; C | 2018 |
Abuse and dependence liability analysis of methylphenidate in the spontaneously hypertensive rat model of attention-deficit/hyperactivity disorder (ADHD): what have we learned?
Topics: Animals; Attention Deficit Disorder with Hyperactivity; Behavior, Addictive; Behavior, Animal; Blood | 2013 |
5 trials available for methylphenidate and Blood Pressure, High
| Article | Year |
|---|---|
Genome-wide association study of blood pressure response to methylphenidate treatment of attention-deficit/hyperactivity disorder.
Topics: Administration, Cutaneous; Attention Deficit Disorder with Hyperactivity; Blood Pressure; Central Ne | 2011 |
Blood pressure changes associated with medication treatment of adults with attention-deficit/hyperactivity disorder.
Topics: Adult; Amphetamines; Antidepressive Agents; Attention Deficit Disorder with Hyperactivity; Blood Pre | 2005 |
Effects of methylphenidate on cardiovascular responses in attention deficit hyperactivity disordered adolescents.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Black People; Blood Pressure; Child; Dose | 1989 |
[Practolol in anesthesia (ICI 50.172, Eraldin)].
Topics: Acetanilides; Adolescent; Adrenergic beta-Antagonists; Adult; Age Factors; Aged; Amino Alcohols; Ane | 1972 |
A pilot study of antihypertensive therapy in cerebrovascular disease.
Topics: Adult; Cerebrovascular Disorders; Clinical Trials as Topic; Depression; Female; Humans; Hypertension | 1967 |
17 other studies available for methylphenidate and Blood Pressure, High
| Article | Year |
|---|---|
Diagnosis and management of an inappropriate sinus tachycardia in adolescence based upon a Holter ECG: A retrospective analysis of 479 patients.
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Electrocardiography, Ambulatory; Fatty Ac | 2020 |
Caregiver survey of pharmacotherapy to treat attention deficit/hyperactivity disorder in individuals with Williams syndrome.
Topics: Adolescent; Amphetamines; Aortic Stenosis, Subvalvular; Attention Deficit Disorder with Hyperactivit | 2013 |
[Cardiovascular side effects secondary to treatment with methylphenidate].
Topics: Central Nervous System Stimulants; Child; Humans; Hypertension; Male; Methylphenidate; Tachycardia | 2010 |
Poison centers' experience with methylphenidate abuse in pre-teens and adolescents.
Topics: Adolescent; Adult; Child; Female; Humans; Hypertension; Male; Methylphenidate; Poison Control Center | 2003 |
Efficacy or effectiveness: which comes first, the cure or the treatment?
Topics: Adolescent; Attention Deficit Disorder with Hyperactivity; Central Nervous System Stimulants; Humans | 2003 |
[Hypertension management in Los; experiences with serpatonil].
Topics: Disease Management; Hypertension; Methylphenidate; Reserpine | 1956 |
[Hypertension management in Los; experiences with serpatonil].
Topics: Disease Management; Hypertension; Methylphenidate; Reserpine | 1956 |
[Hypertension management in Los; experiences with serpatonil].
Topics: Disease Management; Hypertension; Methylphenidate; Reserpine | 1956 |
[Hypertension management in Los; experiences with serpatonil].
Topics: Disease Management; Hypertension; Methylphenidate; Reserpine | 1956 |
[Comparative therapeutic effect of serpasil-ritalin combination].
Topics: Hypertension; Methylphenidate; Reserpine | 1956 |
[Comparative therapeutic effect of serpasil-ritalin combination].
Topics: Hypertension; Methylphenidate; Reserpine | 1956 |
[Comparative therapeutic effect of serpasil-ritalin combination].
Topics: Hypertension; Methylphenidate; Reserpine | 1956 |
[Comparative therapeutic effect of serpasil-ritalin combination].
Topics: Hypertension; Methylphenidate; Reserpine | 1956 |
Treatment of hypertension using reserpine combined with a new analeptic agent, methyl-phenidylacetate hydrochloride; limitations of usefulness.
Topics: Central Nervous System Stimulants; Hypertension; Methylphenidate; Reserpine; Salts | 1957 |
[Ritalin, an adjuvant in the therapy of hypertension].
Topics: Adjuvants, Immunologic; Hypertension; Methylphenidate | 1958 |
Antagonism of guanethidine and bretylium by various agents.
Topics: Bretylium Compounds; Cocaine; Guanethidine; Hypertension; Methylphenidate; Monoamine Oxidase Inhibit | 1962 |
[Clinical experience with an association of reserpine and methylphenidylacetate].
Topics: Hypertension; Methylphenidate; Reserpine | 1959 |
Spontaneously hypertensive rats do not predict symptoms of attention-deficit hyperactivity disorder.
Topics: Age Factors; Animals; Attention Deficit Disorder with Hyperactivity; Behavior, Animal; Central Nervo | 2006 |
Ventricular tachycardia associated with the administration of methylphenidate during guanethidine therapy.
Topics: Drug Synergism; Electrocardiography; Guanethidine; Humans; Hypertension; Male; Methylphenidate; Midd | 1967 |
Clonidine and electrocardiograms.
Topics: Adult; Child; Clonidine; Drug Interactions; Electrocardiography; Humans; Hypertension; Methylphenida | 1996 |
[Pharmacologic incompatibility of neuroleptics and tranquilizers with other medicines].
Topics: Amphetamine; Animals; Anti-Anxiety Agents; Anti-Arrhythmia Agents; Anticonvulsants; Antipsychotic Ag | 1977 |
On the treatment of rapid eye movement narcolepsy.
Topics: Adult; Amphetamine; Antidepressive Agents; Cataplexy; Depression; Desipramine; Electroencephalograph | 1974 |
Methylphenidate and the hyperkinetic state.
Topics: Ataxia; Child; Drug Synergism; Feeding and Eating Disorders; Humans; Hyperkinesis; Hypertension; Met | 1971 |